These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2256151)

  • 1. A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients.
    Pearson RC; Johnson RW; Bakran A; Dyer P; Martin S; O'Donoghue D; Scott PD
    Transplantation; 1990 Dec; 50(6):1061-3. PubMed ID: 2256151
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
    O'Donoghue DJ; Johnson RW; Mallick NP; Gokal R; Ballardie FW; Bakran A; Pearson R; Scott P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 4. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cyclosporin A supplementation and on renal allograft survival in ALS plus bone marrow treated dogs.
    Hartner WC; De Fazio SR; Markees TG; Khouri WA; Maki T; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):959-60. PubMed ID: 2650299
    [No Abstract]   [Full Text] [Related]  

  • 6. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of early renal allograft function with initiation of ALG pretransplant.
    Hong JH; Sumrani N; Delaney V; Butt KM; Sommer BG
    Transplantation; 1992 Jan; 53(1):214-6. PubMed ID: 1733070
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients.
    Lewis R; Hodge E; Novick A; Steinmuller D; Streem S; Cunningham R; Swift C; Goormastic M; Badhwar K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2088-92. PubMed ID: 3029914
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
    Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB; Johnson CP; Roza AM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 14. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

  • 16. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
    Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclosporine A treatment on induction of donor specific unresponsiveness in mongrel dogs following a short course of ALS and donor bone marrow infusion on canine renal allograft function.
    Hartner WC; Shaffer D; Markees TG; De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):477-9. PubMed ID: 1990590
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV; Andersen RC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract]   [Full Text] [Related]  

  • 20. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.